Family · Pharmaceutical analytical standards
Idarubicin
An anthracycline obtained in Italy in the mid-1970s by modifying daunorubicin, hence its chemical name 4-demethoxydaunorubicin; approved in the United States in 1990, it is used mainly in acute myeloid leukaemia. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Compared with daunorubicin it lacks just one methoxy group: this small change makes it an anthracycline that works even when taken by mouth.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
